Press Releases
- BAYER AND EVOTEC UPDATE FOCUS OF THEIR COLLABORATION TO CARDIOVASCULAR DISEASES
- STRATEGIC ALLIANCE LEVERAGES HUMAN INDUCED PLURIPOTENT STEM CELL DISEASE MODELLING FOR IDENTIFICATION OF NOVEL TARGETS
- JOINT EFFORT AIMS TO DEVELOP INNOVATIVE THERAPIES IN PRECISION CARDIOLOGY
BERLIN AND HAMBURG, GERMANY / ACCESSWIRE / April 30, 2024 / Bayer and the German-based life science company, Evotec, announced today that they have updated the focus of their strategic collaboration to... (continue reading...)
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeabrdn... (continue reading...)As provided in Section XI ‘Calculation of the Net Asset Value’ of the Articles of Association of INVL Technology, the net asset value of the Company was EUR 43,807,390 or EUR 3.6281 per share on 31 March 2024.
The person authorized to provide additional information: Kazimieras Tonkūnas INVL Technology Managing Partner E-mail [email protected]
Verkkokauppa.com Oyj - Managers' Transactions – Arja Talma
Verkkokauppa.com Oyj MANAGERS’ TRANSACTIONS 30 April 2024 at 9:45 EET
On 4 April 2024, the Annual General Meeting of Verkkokauppa.com Oyj resolved that the annual fee of the company's Board of Directors is paid in four equal instalments in Verkkokauppa.com shares either purchased from the market or alternatively by using treasury shares held by the company. In accordance with the resolution, a total of... (continue reading...)
Value accretive transaction underpinned by €2.4 billion (NPV) of readily executable synergies.
Creating a stronger multi-orbit operator with ~60% of revenue in high growth segments.
Enhances competitive offerings to deliver customer value through segment-relevant solutions.
Expanded cash flows, profitable growth outlook, & strong balance sheet drive total shareholder return.
LUXEMBOURG & MCLEAN, Va.--(BUSINESS WIRE)-- SES S.A. (“SES”) and Intelsat... (continue reading...)
More Press Releases
View Older Stories-
Verkkokauppa.com Oyj - Managers' Transactions – Enel Sintonen
-
Verkkokauppa.com Oyj - Managers' Transactions – Irmeli Rytkönen
-
Verkkokauppa.com Oyj - Managers' Transactions – Kati Riikonen
-
Verkkokauppa.com Oyj - Managers' Transactions – Henrik Pankakoski
-
INVL Technology interim information for 3 months of 2024
-
Verkkokauppa.com Oyj - Managers' Transactions – Robin Bade
-
Share buybacks in Spar Nord Bank – transactions in week 17
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Havila Shipping ASA: Notice of Ordinary General Meeting
-
111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow
-
Pernod Ricard Successfully Completes Bond Issuance: €1.5 Billion in 2 Tranches
-
Terranet publishes the annual report for 2023
-
Issue of new VINCI shares, reserved for group employees in France in the context of its savings plan
-
Audited annual report of Trigon Property Development AS for 2023
-
Ex-day of dividends allocated by the shareholders' meeting of Invalda INVL held on 30/04/2024
-
Resolutions of the shareholders' meeting of Invalda INVL held on 30/04/2024
-
Mkango Releases Year-end 2023 Financial Statements
-
Euronext upgraded to ‘BBB+, Positive Outlook‘ by S&P
-
Air France-KLM Q1 2024 results
-
Mercedes-Benz Q1 Marked by Solid Cash Generation and Top-End Model Changeovers
-
Genflow Biosciences PLC Announces Total Voting Rights
-
Resolutions of the General Ordinary Shareholders Meeting of INVL Technology
-
GTT: NOTICE OF AVAILABILITY OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT
-
Stellantis Reports Q1 2024 Net Revenues and Shipments Reflecting New Product Transition
-
Stellantis Reports Q1 2024 Net Revenues and Shipments Reflecting New Product Transition
-
Poolbeg Pharma PLC Announces Appointment of Joint Broker
-
Arrow Announces Grant of Stock Options
-
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Apr 30
-
The Pebble Group PLC Announces Directorate Change
-
The Pebble Group PLC Announces AGM Trading Update and Notice of Results
-
Centamin PLC Announces Total Voting Rights
-
Trident Royalties PLC Announces Notice of Q1 2024 Activities Update
-
HYPER Corporation Affiliate Fingerlabs Officially Launches 'Begins≠Youth' , a Derivative Drama Based on BTS' 'Hwa Yang Yeon Hwa', Exclusively on Xclusive Today
-
Gaotu Techedu to Report First Quarter 2024 Financial Results on May 21, 2024
-
Empowering Investors: Keytom Unveils Investment Strategies for Digital Assets
-
Shohei Ohtani Signs Global Partnership with ITO EN's Green Tea Brand "Oi Ocha"
-
Scientific leaders gather at global summit in Denmark to advance knowledge and solutions on health and sustainability
-
emeis Sells a Real-Estate Portfolio in the Netherlands Worth a Total Value of Around €97 Million
-
Galantas Gold Grants Stock Options
-
DACTA and Heimdal Announce Strategic Partnership to Expand Advanced Cybersecurity Solutions in the APAC Region
-
Gensource Potash Releases Audited Financial Statements and Management’s Discussion and Analysis for the Year Ended December 31, 2023
-
USound and Minami Sign Partnership to Facilitate New Collaborations with Top-Tier Brands
-
ACTICOR BIOTECH: Postponement of the Publication of Annual Results and Universal Registration Document 2023
-
Notifications on the transactions concluded by manager in issuer's securities
-
Ignitis Group to present 3M 2024 results and Strategic Plan 2024–2027 on 15 May
-
CoinShares Publishes 2023 Annual Report and Outlines Strategy
-
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
-
Irish Residential Properties Sub-Fund 1: Form 8.3 - Irish Residential Properties REIT PLC
-
Transaction in own shares